Last updated: 5 March 2024 at 6:05pm EST

Andrew Obenshain Net Worth




The estimated Net Worth of Andrew Obenshain is at least 492 千$ dollars as of 1 March 2024. Mr Obenshain owns over 6,095 units of Bluebird bio Inc stock worth over 162,399$ and over the last 4 years he sold BLUE stock worth over 329,845$.

Mr Obenshain BLUE stock SEC Form 4 insiders trading

Mr has made over 16 trades of the Bluebird bio Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 6,095 units of BLUE stock worth 9,325$ on 1 March 2024.

The largest trade he's ever made was selling 21,805 units of Bluebird bio Inc stock on 4 August 2022 worth over 95,724$. On average, Mr trades about 3,098 units every 53 days since 2021. As of 1 March 2024 he still owns at least 279,998 units of Bluebird bio Inc stock.

You can see the complete history of Mr Obenshain stock trades at the bottom of the page.





Mr. Andrew Obenshain biography

Andrew Obenshain is the Pres, CEO & Director at Bluebird bio Inc.



How old is Mr Obenshain?

Mr Obenshain is 46, he's been the Pres、 CEO & Director of Bluebird bio Inc since . There are 20 older and 2 younger executives at Bluebird bio Inc. The oldest executive at Bluebird bio Inc is Wendy Dixon, 64, who is the Independent Director.

What's Mr Obenshain's mailing address?

Andrew's mailing address filed with the SEC is C/O BLUEBIRD BIO, INC., 455 GRAND UNION BOULEVARD, SOMERVILLE, MA, 02145.

Insiders trading at Bluebird bio Inc

Over the last 11 years, insiders at Bluebird bio Inc have traded over 130,743,125$ worth of Bluebird bio Inc stock and bought 6,469 units worth 399,874$ . The most active insiders traders include Steven GillisJohn MaraganoreRobert I Tepper. On average, Bluebird bio Inc executives and independent directors trade stock every 8 days with the average trade being worth of 6,033$. The most recent stock trade was executed by Thomas J Klima on 3 June 2024, trading 3,834 units of BLUE stock currently worth 3,719$.



What does Bluebird bio Inc do?

we are leading the gene therapy revolution. our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. we have a lot of energy, and it’s not just the abundance of coffee that keeps us going. find out what sparks our excitement and inspires us every day.



Complete history of Mr Obenshain stock trades at Bluebird bio Inc

インサイダー
取引
取引
合計金額
Andrew Obenshain
社長、CEO
販売 9,325$
1 Mar 2024
Andrew Obenshain
社長、CEO
販売 1,691$
5 Feb 2024
Andrew Obenshain
社長、CEO
販売 4,522$
5 Jan 2024
Andrew Obenshain
社長、CEO
販売 2,558$
3 Nov 2023
Andrew Obenshain
社長、CEO
販売 59,929$
10 Aug 2023
Andrew Obenshain
社長、CEO
販売 24,788$
11 Jan 2023
Andrew Obenshain
社長、CEO
販売 8,096$
4 Nov 2022
Andrew Obenshain
社長、CEO
販売 95,724$
4 Aug 2022
Andrew Obenshain
社長、CEO
販売 73,619$
10 Jan 2022
Andrew Obenshain
社長、CEO
販売 8,470$
7 Dec 2021
Andrew Obenshain
社長、CEO
販売 15,713$
4 Jun 2021
Andrew Obenshain
社長、CEO
販売 874$
3 May 2021
Andrew Obenshain
社長、CEO
販売 876$
5 Apr 2021
Andrew Obenshain
社長、CEO
販売 1,006$
2 Mar 2021
Andrew Obenshain
社長、CEO
販売 21,092$
16 Feb 2021
Andrew Obenshain
社長、CEO
販売 1,562$
2 Feb 2021


Bluebird bio Inc executives and stock owners

Bluebird bio Inc executives and other stock owners filed with the SEC include: